Literature DB >> 29895678

Update and extension of the 'equivalent slope' of speed-changing level locomotion in humans: a computational model for shuttle running.

Alberto E Minetti1,2, Gaspare Pavei3.   

Abstract

Controlled experimental protocols for metabolic cost assessment of speed-changing locomotion are quite complex to design and manage. The use of the 'equivalent slope', i.e. the gradient locomotion at constant speed metabolically equivalent to a level progression in acceleration, has proved valuable in the estimation of the metabolic cost of speed-changing gaits. However, its use with steep slopes requires extrapolation of the experimental cost versus gradient function for constant running speed, resulting in less-reliable estimates. The present study extended the model to also work with deceleration, and revised the predictive equation to enable it to be applied to much higher levels of speed change. Shuttle running at different distances (from 5+5 to 20+20 m) was then investigated using the novel approach and software, and the predictions in terms of metabolic cost and efficiency compare well with the experimental data.
© 2018. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Acceleration; Cost of transport; Deceleration; Running; Unsteady

Mesh:

Year:  2018        PMID: 29895678     DOI: 10.1242/jeb.182303

Source DB:  PubMed          Journal:  J Exp Biol        ISSN: 0022-0949            Impact factor:   3.312


  2 in total

1.  The Validity of an Updated Metabolic Power Algorithm Based upon di Prampero's Theoretical Model in Elite Soccer Players.

Authors:  Cristian Savoia; Johnny Padulo; Roberto Colli; Emanuele Marra; Allistair McRobert; Neil Chester; Vito Azzone; Samuel A Pullinger; Dominic A Doran
Journal:  Int J Environ Res Public Health       Date:  2020-12-20       Impact factor: 3.390

2.  Biomechanical and metabolic aspects of backward (and forward) running on uphill gradients: another clue towards an almost inelastic rebound.

Authors:  L Rasica; S Porcelli; A E Minetti; G Pavei
Journal:  Eur J Appl Physiol       Date:  2020-08-25       Impact factor: 3.078

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.